Role of myostatin in wasting syndrome associated with chronic diseases;Papel de la miostatina en la afectación muscular asociada a las enfermedades crónicas

Medicina Clinica

Volumn 131, Issue 15, 2008, Pages 585-590

  Zamora, Elisabet ^a   Galán, Amparo ^b   Simó, Rafael ^c  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Muscle wasting; Myostatin; Sarcopenia

Indexed keywords

MYOSTATIN; TRANSFORMING GROWTH FACTOR BETA;

CHRONIC DISEASE; CLINICAL STUDY; DISEASE ASSOCIATION; HUMAN; KNOCKOUT MOUSE; MUSCLE METABOLISM; NONHUMAN; PATHOPHYSIOLOGY; REVIEW; WASTING SYNDROME; WESTERN BLOTTING;

EID: 63149092447     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1157/13128019     Document Type: Review

References (60)

1. Anker S.D., and Coats A.J. Cardiac cachexia: a syndrome with impaired survival and immune and neuroendocrine activation. Chest 115 (1999) 836-847
2. McPherron A.C., Lawler A.M., and Lee S.J. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 387 (1997) 83-90
3. Dickman S. Gene mutation provides more meat on the hoof. Science 277 (1997) 1922-1923
4. Grobet L., Martin L.J., Poncelet D., Pirottin D., Brouwers B., Riquet J., et al. A deletion in the bovine myostatin gene causes the double-muscled phenotype in cattle. Nat Genet 17 (1997) 71-74
5. Grobet L., Poncelet D., Royo L.J., Brouwers B., Pirottin D., Michaux C., et al. Molecular definition of an allelic series of mutations disrupting the myostatin function and causing double-muscling in cattle. Mamm Genome 9 (1998) 210-213
6. Kambadur R., Sharma M., Smith T.P., and Bass J.J. Mutations in myostatin (GDF8) in double-muscled Belgian Blue and Piedmontese cattle. Genome Res 7 (1997) 910-916
7. McPherron A.C., and Lee S.J. Double muscling in cattle due to mutations in the myostatin gene. Proc Natl Acad Sci U S A 94 (1997) 12457-12461
8. McPherron A.C., and Lee S.J. Suppression of body fat accumulation in myostatin-deficient mice. J Clin Invest 109 (2002) 595-601
9. Saunders M.A., Good J.M., Lawrence E.C., Ferrell R.E., Li W.H., and Nachman M.W. Human adaptive evolution at myostatin (GDF8), a regulator of muscle growth. Am J Hum Genet 79 (2006) 1089-1097
10. Zhu X., Hadhazy M., Wehling M., Tidball J.G., and McNally E.M. Dominant negative myostatin produces hypertrophy without hyperplasia in muscle. FEBS Lett 474 (2000) 71-75
11. Yang J., Ratovitski T., Brady J.P., Solomon M.B., Wells K.D., and Wall R.J. Expression of myostatin pro domain results in muscular transgenic mice. Mol Reprod Dev 60 (2001) 351-361
12. Lee S.J., and McPherron A.C. Regulation of myostatin activity and muscle growth. Proc Natl Acad Sci U S A 98 (2001) 9306-9311
13. Schuelke M., Wagner K.R., Stolz L.E., Hubner C., Riebel T., Komen W., et al. Myostatin mutation associated with gross muscle hypertrophy in a child. N Engl J Med 350 (2004) 2682-2688
14. Taylor W.E., Bhasin S., Artaza J., Byhower F., Azam M., Willard Jr. D.H., et al. Myostatin inhibits cell proliferation and protein synthesis in C2C12 muscle cells. Am J Physiol Endocrinol Metab 280 (2001) E221-E228
15. González-Cadavid N.F., Taylor W.E., Yarasheski K., Sinha-Hikim I., Ma K., Ezzat S., et al. Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting. Proc Natl Acad Sci U S A 95 (1998) 14938-14943
16. Sharma M., Kambadur R., Matthews K.G., Somers W.G., Devlin G.P., Conaglen J.V., et al. Myostatin, a transforming growth factor-beta superfamily member, is expressed in heart muscle and is upregulated in cardiomyocytes after infarct. J Cell Physiol 180 (1999) 1-9
17. Ríos R., Fernández-Nocelos S., Carneiro I., Arce V.M., and Devesa J. Differential response to exogenous and endogenous myostatin in myoblasts suggests that myostatin acts as an autocrine factor in vivo. Endocrinology 145 (2004) 2795-2803
18. Reisz-Porszasz S., Bhasin S., Artaza J.N., Shen R., Sinha-Hikim I., Hogue A., et al. Lower skeletal muscle mass in male transgenic mice with musclespecific overexpression of myostatin. Am J Physiol Endocrinol Metab 285 (2003) E876-E888
19. Lang C.H., Silvis C., Nystrom G., and Frost R.A. Regulation of myostatin by glucocorticoids after thermal injury. FASEB J 15 (2001) 1807-1809
20. Zimmers T.A., Davies M.V., Koniaris L.G., Haynes P., Esquela A.F., Tomkinson K.N., et al. Induction of cachexia in mice by systemically administered myostatin. Science 296 (2002) 1486-1488
21. Willoughby D.S., and Wilborn C. Estradiol in females may negate skeletal muscle myostatin mRNA expression and serum myostatin propeptide levels after eccentric muscle contractions. Journal of Sports Science and Medicine 5 (2006) 672-681
22. Hill J.J., Davies M.V., Pearson A.A., Wang J.H., Hewick R.M., Wolfman N.M., et al. The myostatin propeptide and the follistatin-related gene are inhibitory binding proteins of myostatin in normal serum. J Biol Chem 277 (2002) 40735-40741
23. Wolfman N.M., McPherron A.C., Pappano W.N., Davies M.V., Song K., Tomkinson K.N., et al. Activation of latent myostatin by the BMP-1/tolloid family of metalloproteinases. Proc Natl Acad Sci U S A 100 (2003) 15842-15846
24. Szabo G., Dallmann G., Muller G., Patthy L., Soller M., and Varga L. A deletion in the myostatin gene causes the compact (Cmpt) hypermuscular mutation in mice. Mamm Genome 9 (1998) 671-672
25. Walsh F.S., and Celeste A.J. Myostatin: a modulator of skeletal-muscle stem cells. Biochem Soc Trans 33 (2005) 1513-1517
26. Thomas M., Langley B., Berry C., Sharma M., Kirk S., Bass J., et al. Myostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferation. J Biol Chem 275 (2000) 40235-40243
27. Kim J.S., Cross J.M., and Bamman M.M. Impact of resistance loading on myostatin expression and cell cycle regulation in young and older men and women. Am J Physiol Endocrinol Metab 288 (2005) E1110-E1119
28. Hosoyama T., Tachi C., Yamanouchi K., and Nishihara M. Long term adrenal insufficiency induces skeletal muscle atrophy and increases the serum levels of active form myostatin in rat serum. Zoolog Sci 22 (2005) 229-236
29. Amthor H., Macharia R., Navarrete R., Schuelke M., Brown S.C., Otto A., et al. Lack of myostatin results in excessive muscle growth but impaired force generation. Proc Natl Acad Sci U S A 104 (2007) 1835-1840
30. Marcell T.J., Harman S.M., Urban R.J., Metz D.D., Rodgers B.D., and Blackman M.R. Comparison of GH, IGF-I, and testosterone with mRNA of receptors and myostatin in skeletal muscle in older men. Am J Physiol Endocrinol Metab 281 (2001) E1159-E1164
31. McNally E.M. Powerful genes - myostatin regulation of human muscle mass. N Engl J Med 350 (2004) 2642-2644
32. Matsuda T., Yamamoto T., Muraguchi A., and Saatcioglu F. Cross-talk between transforming growth factor-β and estrogen receptor signaling through Smad3. J Biol Chem 276 (2001) 42908-42914
33. Ji S., Losinski R.L., Cornelius S.G., Frank G.R., Willis G.M., Gerrard D.E., et al. Myostatin expression in porcine tissues: tissue specificity and developmental and postnatal regulation. Am J Physiol 275 (1998) R1265-R1273
34. Ivey F.M., Roth S.M., Ferrell R.E., Tracy B.L., Lemmer J.T., Hurlbut D.E., et al. Effects of age, gender, and myostatin genotype on the hypertrophic response to heavy resistance strength training. J Gerontol A Biol Sci Med Sci 55 (2000) M641-M648
35. Schiessl H., Frost H., and Jee W. Estrogen and bone-muscle strength and mass relationships. Bone 22 (1998) 1-6
36. McMahon C.D., Popovic L., Jeanplong F., Oldham J.M., Kirk S.P., Osepchook C.C., et al. Sexual dimorphism is associated with decreased expression of processed myostatin in males. Am J Physiol Endocrinol Metab 284 (2003) E377-E381
37. McMahon C.D., Popovic L., Oldham J.M., Jeanplong F., Smith H.K., Kambadur R., et al. Myostatin-deficient mice lose more skeletal muscle mass than wild-type controls during hindlimb suspension. Am J Physiol Endocrinol Metab 285 (2003) E82-E87
38. Schulte J.N., and Yarasheski K.E. Effects of resistance training on the rate of muscle protein synthesis in frail elderly people. Int J Sport Nutr Exerc Metab 11 Suppl (2001) 111-118
39. Yarasheski K.E., Bhasin S., Sinha-Hikim I., Pak-Loduca J., and González-Cadavid N.F. Serum myostatin-immunoreactive protein is increased in 60-92 year old women and men with muscle wasting. J Nutr Health Aging 6 (2002) 343-348
40. 3 administration. J Gravit Physiol 6 (1999) 11-15
41. Reardon K.A., Davis J., Kapsa R.M., Choong P., and Byrne E. Myostatin, insulinlike growth factor-1, and leukemia inhibitory factor mRNAs are upregulated in chronic human disuse muscle atrophy. Muscle Nerve 24 (2001) 893-899
42. Wehling M., Cai B., and Tidball J.G. Modulation of myostatin expression during modified muscle use. FASEB J 14 (2000) 103-110
43. Lalani R., Bhasin S., Byhower F., Tarnuzzer R., Grant M., Shen R., et al. Myostatin and insulin-like growth factor-I and -II expression in the muscle of rats exposed to the microgravity environment of the NeuroLab space shuttle flight. J Endocrinol 167 (2000) 417-428
44. Welle S., Bhatt K., Shah B., and Thornton C. Insulin-like growth factor-1 and myostatin mRNA expression in muscle: comparison between 62-77 and 21-31 yr old men. Exp Gerontol 37 (2002) 833-839
45. Kopple J.D., Cohen A.H., Wang H., Qing D., Tang Z., Fournier M., et al. Effect of exercise on mRNA levels for growth factors in skeletal muscle of hemodialysis patients. J Ren Nutr 16 (2006) 312-324
46. Artaza J.N., Bhasin S., Mallidis C., Taylor W., Ma K., and González-Cadavid N.F. Endogenous expression and localization of myostatin and its relation to myosin heavy chain distribution in C2C12 skeletal muscle cells. J Cell Physiol 190 (2002) 170-179
47. Ma K., Mallidis C., Bhasin S., Mahabadi V., Artaza J., Gonzalez-Cadavid N., et al. Glucocorticoid-induced skeletal muscle atrophy is associated with upregulation of myostatin gene expression. Am J Physiol Endocrinol Metab 285 (2003) E363-E371
48. Ma K., Mallidis C., Artaza J., Taylor W., González-Cadavid N., and Bhasin S. Characterization of 5'-regulatory region of human myostatin gene: regulation by dexamethasone in vitro. Am J Physiol Endocrinol Metab 281 (2001) E1128-E1136
49. Feldman B.J., Streeper R.S., Farese Jr. R.V., and Yamamoto K.R. Myostatin modulates adipogenesis to generate adipocytes with favorable metabolic effects. Proc Natl Acad Sci U S A 103 (2006) 15675-15680
50. Gilson H., Schakman O., Combaret L., Lause P., Grobet L., Attaix D., et al. Myostatin gene deletion prevents glucocorticoid-induced muscle atrophy. Endocrinology 148 (2007) 452-460
51. Carlson C.J., Booth F.W., and Gordon S.E. Skeletal muscle myostatin mRNA expression is fiber-type specific and increases during hindlimb unloading. Am J Physiol 277 (1999) R601-R606
52. Dekhuijzen P., Gayan-Ramírez G., Bisshop A., De Bock V., Dom R., and Decramer M. Corticosteroid treatment and nutritional deprivation cause a different pattern of atrophy in rat diaphragm. J Apply Physiol 78 (1995) 629-637
53. Tsuchida K. Activins, myostatin and related TGF-beta family members as novel therapeutic targets for endocrine, metabolic and immune disorders. Curr Drug Targets Immune Endocr Metabol Disord 4 (2004) 157-166
54. Lee S.J., Reed L.A., Davies M.V., Girgenrath S., Goad M.E., Tomkinson K.N., et al. Regulation of muscle growth by multiple ligands signaling through activin type II receptors. Proc Natl Acad Sci U S A 102 (2005) 18117-18122
55. Bogdanovich S., Krag T.O., Barton E.R., Morris L.D., Whittemore L.A., Ahima R.S., et al. Functional improvement of dystrophic muscle by myostatin blockade. Nature 420 (2002) 418-421
56. Whittemore L.A., Song K., Li X., Aghajanian J., Davies M., Girgenrath S., et al. Inhibition of myostatin in adult mice increases skeletal muscle mass and strength. Biochem Biophys Res Commun 300 (2003) 965-971
57. Sunada Y. Therapeutic strategies for muscular dystrophy by myostatin inhibition. Rinsho Shinkeigaku 46 (2006) 942-944
58. Holzbaur E.L., Howland D.S., Weber N., Wallace K., She Y., Kwak S., et al. Myostatin inhibition slows muscle atrophy in rodent models of amyotrophic lateral sclerosis. Neurobiol Dis 23 (2006) 697-707
59. Tang L., Yan Z., Wan Y., Han W., and Zhang Y. Myostatin DNA vaccine increases skeletal muscle mass and endurance in mice. Muscle Nerve 36 (2007) 342-348
60. Acharyya S., and Guttridge D.C. Cancer cachexia signaling pathways continue to emerge yet much still points to the proteasome. Clin Cancer Res 13 (2007) 1356-1361